Complete Colonic Metaplasia of the Urinary Bladder and Ureters With Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder: A Rare Occurrence.

Int J Surg PatholApr 10, 2026 (epub)

Saikat Mitra, Akshara Shangloo, Milind A Bhatkule et al.

✦ AI-curated · Sources linked

Case in brief

A 56-year-old woman presented with six months of voiding difficulty and hematuria. After radical cystectomy with hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymph node dissection, pathology identified primary signet-ring cell adenocarcinoma of the urinary bladder. The entire bladder mucosa, including the ureteric mucosa, showed complete colonic metaplasia. Immunohistochemistry showed a lower gastrointestinal-type profile, with KRT20 and CDX2 positivity.

What made this case unusual

Complete colonic metaplasia involved both the bladder and ureteric mucosa in a case with primary bladder signet-ring cell adenocarcinoma.

Diagnostic / clinical pearl

In bladder signet-ring cell adenocarcinoma, assess the extent of mucosal metaplasia and interpret KRT20 and CDX2 positivity in the context of the primary bladder diagnosis.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.